Techniques to monitor and trend nerve damage and recovery

Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C607S116000, C607S117000, C607S118000, C600S546000, C600S547000, C600S548000

Reexamination Certificate

active

07634315

ABSTRACT:
An exemplary method includes implementing a nerve stimulation therapy that includes delivering stimulation energy to a target nerve, periodically acquiring compound action potentials responsive to the delivered stimulation energy and assessing condition of the target nerve based at least in part on the periodically acquired compound action potentials. Various other exemplary methods, devices, systems, etc., are also disclosed.

REFERENCES:
patent: 5540734 (1996-07-01), Zabara
patent: 5702429 (1997-12-01), King
patent: 5860939 (1999-01-01), Wofford et al.
patent: 6070100 (2000-05-01), Bakels et al.
patent: 6238423 (2001-05-01), Bardy
patent: 6832114 (2004-12-01), Whitehurst et al.
patent: 7192922 (2007-03-01), Shannon et al.
patent: 7215992 (2007-05-01), Stahmann et al.
patent: 7326181 (2008-02-01), Katims
patent: 2002/0120200 (2002-08-01), Brockway et al.
patent: 2005/0043675 (2005-02-01), Pastore et al.
patent: 2005/0149151 (2005-07-01), Orszulak et al.
patent: 2005/0288721 (2005-12-01), Girouard et al.
patent: 2006/0116736 (2006-06-01), DiLorenzo
patent: 2006/0178691 (2006-08-01), Binmoeller
patent: 2007/0060971 (2007-03-01), Glasberg et al.
patent: 2009/0062881 (2009-03-01), Gross et al.
patent: 1486232 (2004-12-01), None
patent: 1486232 (2004-12-01), None
patent: 2004112563 (2004-12-01), None
patent: 2004112563 (2004-12-01), None
patent: WO2005/087310 (2005-09-01), None
Bose et al., “Glucagon-Like Peptide 1 Can Directly Protect the Heart Against Ischemia/Reperfusion Injury”, Diabetes, vol. 54, Jan. 2005.
Han et al., “Comparisons between neural response imaging thresholds, electrically evoked auditory reflex thresholds and most comfortable loudness levels in CII bionic ear users with HiResolution sound processing strategies”, Acta Otolaryngol. Jul. 2005;125(7):732-5.
Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution”, Anat Embryol. (2005) 209: 425-438.
Koga et al., “Selective activation of primary afferent fibers evaluated by sine-wave electrical stimulation”, Molecular Pain 20-05, I:13.
Konturek et al., “Brain-gut Axis and Its Role in the Control of Food Intake”, J Physiol. Pharma. 2004, 55, 1, 137-154.
Nikolaidis et al., “Recombinant Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake and Improves Left Ventricular Performance in Conscious Dogs With Pacing-Induced Dilated Cardiomyopathy” Circulation 2004 110: 955-961.
Pauza et al., “Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart”, The Anatomical Record (2000) 259(4): 353-38.
Rocca and Brubaker, “Role of the Vagus Nerve in Mediating Proximal Nutrient-Induced Glucagon-Like Peptide-1 Secretion”, Endocrinology 140: 1687-1694, 1999.
Schauer et al., “Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus”, Ann Surg 2003; 238:467-485.
Taegtmeyer, “Cardiac Metabolism as a Target for the Treatment of Heart Failure”, Circulation 2004; 110: 894-896.
Wettergren et al., “The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7-36 amide on gastric acid secretion in humans depends on an intact vagal innervation”, Gut 1997;40;597-601.
European Search Report, dated Aug. 1, 2008: Related Application 08251919.0.
European Search Report, dated Aug. 1, 2008: Related Application 08251920.0.
NonFinal Office Action, mailed Sep. 4, 2009 - Related U.S. Appl. No. 11/756,435.
NonFinal Office Action, mailed Sep. 4, 2009 - Related U.S. Appl. No. 11/756,451.
NonFinal Office Action, mailed Sep. 10, 2009 - Related U.S. Appl. No. 11/756,464.
NonFinal Office Action, mailed Sep. 10, 2009 - Related U.S. Appl. No. 11/756,478.
NonFinal Office Action, mailed Sep. 9, 2009 - Related U.S. Appl. No. 11/756,515.
NonFinal Office Action, mailed Jul. 23, 2009 - Related U.S. Appl. No. 11/756,405.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Techniques to monitor and trend nerve damage and recovery does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Techniques to monitor and trend nerve damage and recovery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Techniques to monitor and trend nerve damage and recovery will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4128307

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.